Nu Skin Enterprises, Inc. (NUS) Balance Sheet

The balance sheet has undergone a fundamental transformation: total assets fell from $1.7 billion to $1.1 billion while liabilities were reduced from $931.7 million to $578.8 million, yet the net effect still left equity 33% lower at $542.7 million. This pattern suggests management has been deleveraging and shrinking the balance sheet reactively in response to revenue contraction rather than through strategic capital allocation. The trajectory implies the company is becoming a materially smaller enterprise with progressively fewer financial buffers, which may constrain its ability to fund turnaround initiatives if operating losses persist.

The near-total elimination of goodwill across three successive impairment rounds — $130.9 million in 2024Q2, $16.3 million in 2024Q4, and $78.8 million in 2026Q2 — confirms that acquisition-driven growth value has been effectively written off, consistent with the $249.8 million net loss reported in 2026Q2. Net PPE has declined steadily from $515.9 million to $445.0 million, a pattern consistent with depreciation outpacing reinvestment and aligning with the declining D&A trend observed in cash flow analysis. With PPE now representing roughly 40% of total assets, the balance sheet appears heavily concentrated in physical assets that may be generating diminishing returns given the sustained top-line contraction.

The $251 million equity decline between 2026Q1 and 2026Q2 alone represents a 32% quarterly drop, far exceeding any prior erosion observed in the dataset and directly reflecting the $249.8 million net loss alongside the $78.8 million goodwill impairment. Retained earnings fell from $1.9 billion to $1.6 billion over the same span, though the approximate $300 million decline suggests additional charges beyond the reported net loss may have contributed. Equity now represents just 49% of total assets versus 48% in 2024Q1, but the rapid Q1-to-Q2 deterioration indicates the book value buffer against further write-downs has narrowed materially.

Debt reduction from $557.4 million to $263.7 million is the most constructive balance sheet trend over the period, suggesting management has prioritized de-risking the capital structure even as operations deteriorate. However, the D/E improvement appears partly mechanical — equity fell by $267 million over the same ten quarters — meaning the ratio trajectory could reverse if debt stabilizes while losses continue eroding the equity base. Investors should monitor whether the remaining $263.7 million in debt carries manageable refinancing terms, as the shrinking asset base provides progressively less collateral support and the current ratio, while stable near 1.98, does not directly address long-term debt service capacity.